During the last session, Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN)’s traded shares were 1.2 million, with the beta value of the company hitting 0.74. At the
In the last trading session, 6.19 million shares of the Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) were traded, and its beta was 0.76. Most recently the
In the latest trading session,, 20.15 million Sonnet BioTherapeutics Holdings Inc (NASDAQ:SONN) shares changed hands as the company’s beta touched 0.91. With the company’s most
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne